Zachary R. Hunter

Also affiliated with International Waldenstrom's Macroglobulinemia Foundation, Dana-Farber Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia”.

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

Leukemia(2021)10.1038/s41375-021-01417-9

N/A

1.8DataRank · unranked

83 citations

Kirsten Meid, Joshua Gustine, Carly Leventoff, Timothy P. White, Catherine Flynn +17 more

Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia

Blood(2021)10.1182/blood.2021012953

N/A

1.4DataRank · unranked

53 citations

Kirsten Meid, Zachary R. Hunter, Catherine Flynn, Shayna Sarosiek, Carly Leventoff +17 more

A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings

Frontiers in Immunology(2025)10.3389/fimmu.2024.1369619

N/A

0.343DataRank · unranked

7 citations

Camille N. Kotton, Jae‐Hyun Park, Giorgia Moranzoni, Camilla K. Lemvigh, Joseph Gathe +30 more

The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance

Blood(2021)10.1182/blood.2021011405

N/A

0DataRank · unranked

28 citations

Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides +17 more

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Blood(2021)10.1182/blood.2021011452

N/A

0DataRank · unranked

21 citations

Hervé Avet‐Loiseau, Raphaël Szalat, Anıl Aktaş Samur, Zachary R. Hunter, Masood A. Shammas +9 more

Cell‐free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia

American Journal of Hematology(2021)10.1002/ajh.26184

N/A

0DataRank · unranked

12 citations

Zachary R. Hunter, Lian Xu, Nicholas Tsakmaklis, Amanda Kofides, Manit Munshi +14 more

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Blood Advances(2022)10.1182/bloodadvances.2021006147

N/A

0DataRank · unranked

15 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter +18 more

Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia

Experimental Hematology and Oncology(2022)10.1186/s40164-022-00305-x

N/A

0DataRank · unranked

14 citations

Zachary R. Hunter, Mariateresa Fulciniti, Annamaria Gullà, Ida Perrotta, Valeria Zuccalà +18 more

Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia

International Journal of Cancer(2022)10.1002/ijc.34405

N/A

0DataRank · unranked

9 citations

Gábor Beke, Zachary R. Hunter, Teru Hideshima, Ludmila M. Flores, Tatiana Zeleznikova +10 more

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

Blood Advances(2024)10.1182/bloodadvances.2023012111

N/A

0DataRank · unranked

4 citations

Jorge J. Castillo, Shayna Sarosiek, Andrew R. Branagan, Catherine Flynn, Kirsten Meid +12 more

ERK1/2 pro‐survival signalling is suppressed by pirtobrutinib in ibrutinib‐resistant MYD88‐mutated lymphoma cells

British Journal of Haematology(2024)10.1111/bjh.19756

N/A

0DataRank · unranked

3 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Zachary R. Hunter, Maria Luisa Guerrera +15 more

Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia

Nature Communications(2025)10.1038/s41467-025-56323-w

N/A

0DataRank · unranked

13 citations

Yoshinobu Konishi, Daniel Heilpern-Mallory, Ting Wu, Nicholas Tsakmaklis, Michelle P. Aranha +17 more

918O Telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with MET-amplified (MET-amp) advanced solid tumors: Results from a phase I study

Annals of Oncology(2025)10.1016/j.annonc.2025.08.1487

N/A

0DataRank · unranked

2 citations

Yasutoshi Kuboki, John H. Strickler, Kanwal Pratap Singh Raghav, Antoine Hollebecque, D.H. Lee +15 more

Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia

British Journal of Haematology(2025)10.1111/bjh.20072

N/A

0DataRank · unranked

1 citations

Xia Liu, Choudhury Fabliha B. Yusuf, Amanda Kofides, Kara M. Soroko, Johany Peñailillo +17 more

SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas

Blood Cancer Journal(2020)10.1038/s41408-020-0277-6

N/A

0DataRank · unranked

47 citations

Xia Liu, Jiaji G. Chen, Lian Xu, Nickolas Tsakmaklis, Maria Demos +19 more

Repurposing pacritinib to target MYD88 ‐mutated Waldenström macroglobulinaemia

British Journal of Haematology(2025)10.1111/bjh.70254

N/A

0DataRank · unranked

0 citations

Amanda Kofides, Xia Liu, John M. Hatcher, Hao Sun, Nicholas Tsakmaklis +11 more

Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas

Blood Advances(2020)10.1182/bloodadvances.2019000947

N/A

0DataRank · unranked

24 citations

Jiaji G. Chen, Manit Munshi, Zachary R. Hunter, Lian Xu, Amanda Kofides +12 more

Genomic evolution of ibrutinib‐resistant clones in Waldenström macroglobulinaemia

British Journal of Haematology(2020)10.1111/bjh.16463

N/A

0DataRank · unranked

36 citations

Gloria Chan, Lian Xu, Nickolas Tsakmaklis, Amanda Kofides, Maria Demos +10 more